This Article Full Text Full Text (PDF) All Versions of this Article: 93/3/901    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lietman, S. A. Articles by Levine, M. A. Search for Related Content PubMed PubMed Citation Articles by Lietman, S. A. Articles by Levine, M. A. Related Collections Pediatric Endocrinology Calcium and Bone Metabolism

Preimplantation Genetic Diagnosis for Severe Albright Hereditary Osteodystrophy

Department of Orthopedic Surgery (S.A.L.), Cleveland Clinic Foundation; Department of Biomedical Engineering (S.A.L., M.A.L.), Cleveland Clinic Lerner Research Institute; Department of Obstetrics and Gynecology (J.G., N.D.), Cleveland Clinic; and Section of Pediatric Endocrinology (M.A.L.), Cleveland Clinic Children’s Hospital, Cleveland, Ohio 44195

Address all correspondence and requests for reprints to: Steven Lietman, M.D., Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Mailstop ND20, Cleveland, Ohio 44195. E-mail: lietmas{at}ccf.org.

Context: Preimplantation genetic diagnosis (PGD) enables the selection of embryos without mutations for implantation and has not been described to our knowledge for mutations in GNAS. Phocomelia in a patient with Albright hereditary osteodystrophy (AHO) has also not been previously described.

Objective: The aim of this study was to identify a GNAS mutation in a patient with a severe form of AHO and pseudohypoparathyroidism type 1a with phocomelia and to perform PGD on embryos derived by in vitro fertilization to deliver an unaffected infant.

Design: A proband and his family are described clinically, the GNAS gene was sequenced to identify a novel mutation in the proband, and PGD was performed on embryos.

Setting: The setting was in a tertiary-care hospital.

Patients: The patients were from a single family in which the proband has a severe form of AHO.

Interventions: Interventions were PGD and in vitro fertilization.

Main Outcome Measures: The main outcome measures were the clinical phenotypes and GNAS gene sequences of the proband, embryos, and family members.

Results: After PGD, three genotypically normal embryos were transferred back to the mother. Pregnancy ensued, and a healthy male infant was delivered at 36.5 wk gestation. The GNAS genes in the baby were confirmed as wild-type, and the infant is free of any signs of AHO.

Conclusions: We describe herein a proband with AHO and severe skeletal deformities (including phocomelia) related to a novel GNAS mutation and the delivery of a male infant with homozygous normal GNAS genotype after PGD.